| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | sTfR1|Soluble Transferrin Receptor1 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human sTfR1 (Soluble Transferrin Receptor1) is a molecular target commonly studied in biomedical research. Soluble receptors are circulating forms of membrane receptors, often generated by shedding or alternative splicing, and they can modulate ligand availability and signaling.
Biological role and mechanism
The biological role of sTfR1 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of sTfR1 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
sTfR1 (Soluble Transferrin Receptor1) may also be referenced as sTfR1 and Soluble Transferrin Receptor1 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how sTfR1 relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.
- Interpreting shifts in sTfR1 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
sTfR1 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Associations between serum levels of ferroptosis-related molecules and outcomes in stable COPD: an exploratory prospective observational study
IF: 3.2 Journal: Internal and Emergency Medicine Author: Department of Pulmonology, Hospital Universitario Marqués de Valdecilla, Santander, Spain. Cited Date: 2025-06-27
TFR1 as a Biomarker of Pulmonary Fibrosis Development in COPD Patients
IF: 3.1 Journal: International Journal of Chronic Obstructive Pulmonary Disease Author: Department of General Medicine, Hunan Provincial People's Hospital and The First-Affiliated of Hospital of Hunan Normal University, Changsha, 410005, People's Republic of China. Cited Date: 2025-08-15
Non-Anemic Iron Deficiency Predicts COPD Exacerbations and Hospitalizations: Results from a Prospective Cohort
IF: 2.9 Journal: Journal of Clinical Medicine Author: Department of Pulmonology, Hospital Universitario Marqués de Valdecilla, 39005 Santander, Spain Cited Date: 2025-06-20
The Relationship of Hepcidin, Soluble Transferrin Receptor, Growth Differentiation Factor-15 And Anemia in Multipl Myeloma
IF: Journal: Konuralp Medical Journal Author: Department of Hematology, Department of Internal Medicine, Duzce Faculty of Medicine, Cited Date: 2023-11-10